Your browser doesn't support javascript.
loading
A pooled analysis of the efficacy of fesoterodine for the treatment of overactive bladder, and the relationship between safety, co-morbidity and polypharmacy in patients aged 65 years or older.
Wagg, Adrian; Arumi, Daniel; Herschorn, Sender; Angulo Cuesta, Javier; Haab, Francois; Ntanios, Fady; Carlsson, Martin; Oelke, Matthias.
Afiliação
  • Wagg A; Geriatric Medicine, University of Alberta, Alberta, Canada.
  • Arumi D; Pfizer Europe-Pfizer Global Innovative Pharma Business, Madrid, Spain.
  • Herschorn S; Urology, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
  • Angulo Cuesta J; Urology, Hospital Universitario de Getafe, Getafe, Madrid, Spain.
  • Haab F; Groupe Hospitalier Diaconess Croix Saint Simon - Urology, Paris, France.
  • Ntanios F; Pfizer Inc, New York, NY, USA.
  • Carlsson M; Pfizer European Service Center BVBA, Brussels, Belgium.
  • Oelke M; Urology, University of Hannover, Hannover, Bavaria, Germany.
Age Ageing ; 46(4): 620-626, 2017 07 01.
Article em En | MEDLINE | ID: mdl-28057620
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Urodinâmica / Compostos Benzidrílicos / Bexiga Urinária / Antagonistas Muscarínicos / Bexiga Urinária Hiperativa / Agentes Urológicos Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Urodinâmica / Compostos Benzidrílicos / Bexiga Urinária / Antagonistas Muscarínicos / Bexiga Urinária Hiperativa / Agentes Urológicos Idioma: En Ano de publicação: 2017 Tipo de documento: Article